Edwards Lifesciences EW Europe — Selling, general, and administrative expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's europe — selling, general, and administrative expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Edwards Lifesciences's europe — selling, general, and administrative expenses?
- Edwards Lifesciences (EW) reported europe — selling, general, and administrative expenses of $71.8M in Q1 2026.
- How has Edwards Lifesciences's europe — selling, general, and administrative expenses changed year-over-year?
- Edwards Lifesciences's europe — selling, general, and administrative expenses decreased by 2.2% year-over-year, from $73.4M to $71.8M.
- What is the long-term trend for Edwards Lifesciences's europe — selling, general, and administrative expenses?
- Over 3 years (2022 to 2025), Edwards Lifesciences's europe — selling, general, and administrative expenses has grown at a 10.6% compound annual growth rate (CAGR), from $233M to $315M.
- What does europe — selling, general, and administrative expenses mean?
- This metric encompasses the operating expenses required to support the sales, marketing, and administrative functions of the European business segment. It includes costs for sales force compensation, regional management, and general corporate support allocated to the European market. It is a key indicator of the investment level required to maintain and grow the company's regional market presence.